PRKAB2 and schizophrenia: Additionally, it indicates that polymorphisms in PRKAB2 are associated with weight gain in patients with schizophrenia or affective disorders treated with antipsychotic drugs (chlorpromazine or olanzapine) (Souza et al., 2012).